0.01
—
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Clever Leaves Holdings
Its shares trade under the ticker CLVR. It has been listed since 18 December 2020. In the fiscal year to 31 December 2023, it reported revenue of $17.4m and a net loss of $17.9m. At that date it held total assets of $31.2m and shareholders' equity of $24.2m.
Clever Leaves Holdings Inc is a CO-based company operating in Pharmaceuticals industry. The company employs 400 full-time employees The company went IPO on 2020-12-18. Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The firm's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. The company offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 18 Dec 2020
- Employees
- 400
Leadership
Pay as last reported
- Mr. Andres FajardoChief Executive Officer, Director, since 2020$1.7m
- Mr. Henry HagueChief Financial Officer$711,015
- Mr. Julian WilchesChief Regulatory Officer$258,099
- Ms. Elisabeth DeMarseIndependent Director$140,562
- Mr. Gary JulienIndependent Director$128,062
- Mr. William MueckeIndependent Director$119,176
- Mr. George SchultzeIndependent Director$144,046
- Ms. Jackie KeshnerInvestor Relations, since 2022
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Clever Leaves Holdings Inc employs 400 full-time employees in the Pharmaceuticals sector.
- The company operates as a multinational licensed producer of pharmaceutical-grade cannabinoids.
- Cannabis and Non-Cannabinoid segments cover cultivation, manufacturing, and distribution of products.
Weaknesses
- The company's IPO was on 18 December 2020, a relatively recent listing date.
- Clever Leaves Holdings Inc has limited customer base in the United States for Herbal Brands.
- The company's product portfolio focuses on nutraceuticals and cannabinoids, which may face market saturation.
Opportunities
- The Cannabinoid segment can expand into new markets within the United States.
- Herbal Brands' nutraceuticals can target specialty and health retailers for growth.
- The Non-Cannabinoid segment can leverage acquired manufacturing assets for innovation.
Threats
- The company faces regulatory challenges in the Pharmaceuticals industry.
- Competition in the cannabinoid market may intensify with new entrants.
- The nutraceutical market is highly competitive with established brands.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.